nan 190 has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Bucki, A; Chrzanowska, A; Czopek, A; Drop, M; Głuch-Lutwin, M; Kołaczkowski, M; Partyka, A; Pawłowski, M; Pękala, E; Siwek, A; Struga, M; Wesołowska, A; Zagórska, A | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Li, J; Pan, J; Wang, R; Wu, S; Xie, X; Xu, Y; Yu, X; Yu, Y; Zheng, L | 1 |
| Costa, EA; Da Rocha, FF; Fajemiroye, JO; Florentino, IF; Galdino, PM; Ghedini, PC; Polepally, PR; Zjawiony, JK | 1 |
| Hu, Y; Huang, XY; Luo, CX; Wu, DL; Wu, HY; Ye, ML; Zhang, J; Zhou, QG; Zhu, DY; Zhu, LJ | 1 |
| Charkhpour, M; Doustar, Y; Hassanzadeh, K; Nayebi, AR | 1 |
| Alves, SF; Costa, EA; de Paula, JA; de Paula, JR; Fajemiroye, JO; Galdino, PM; Ghedini, PC | 1 |
| Egawa, T; Ichimaru, Y; Imanishi, T; Sawa, A | 1 |
| Di Francesco, GF | 1 |
| Chojnacka-Wójcik, E; Filip, M; Przegaliński, E; Tatarczyńska, E | 1 |
| Bagdy, G; Filakovszky, J; Gerber, K; Halasz, P | 1 |
| Masuda, Y; Sugiyama, T | 1 |
13 other study(ies) available for nan 190 and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Humans; Receptors, Serotonin; Structure-Activity Relationship | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Colon; Curcumin; Cyclic AMP Response Element-Binding Protein; Defecation; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Enteric Nervous System; Gastrointestinal Motility; Hippocampus; Imipramine; Irritable Bowel Syndrome; Male; Phosphorylation; Physical Exertion; Piperazines; Pressure; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Signal Transduction; Stress, Physiological; Stress, Psychological; Up-Regulation | 2015 |
Plurality of anxiety and depression alteration mechanism by oleanolic acid.
Topics: alpha-Methyltyrosine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Hippocampus; Imipramine; Male; Mice; Monoamine Oxidase; Motor Activity; Oleanolic Acid; Pentylenetetrazole; Piperazines; Pyridines | 2014 |
Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Animals, Newborn; Anxiety Disorders; CREB-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Feeding Behavior; Fluoxetine; Gene Expression Regulation, Enzymologic; Hippocampus; Indazoles; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type I; Phosphorylation; Piperazines; Reaction Time; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
8-OH-DPAT prevents morphine-induced apoptosis in rat dorsal raphe nucleus: a possible mechanism for attenuating morphine tolerance.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analgesics, Opioid; Animals; Apoptosis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Hot Temperature; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Morphine; Pain; Pain Measurement; Piperazines; Raphe Nuclei; Rats; Rats, Wistar; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
Involvement of 5-HT1A in the anxiolytic-like effect of dichloromethane fraction of Pimenta pseudocaryophyllus.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Ethanol; Flumazenil; GABA Modulators; Male; Methylene Chloride; Mice; Pimenta; Piperazines; Plant Extracts; Plant Leaves; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Antagonists; Solvents | 2012 |
Neither the 5-HT1A- nor the 5-HT2-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on forced-swimming-induced immobility in mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Desipramine; Disease Models, Animal; Drug Interactions; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin Antagonists | 1995 |
Are the cardiovascular effects and '5-HT syndrome' induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension, Renal; Injections, Subcutaneous; Male; Piperazines; Prazosin; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Respiration; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Tachyphylaxis | 1994 |
The role of 5-hydroxytryptamine1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Betaxolol; Conflict, Psychological; Disease Models, Animal; Drug Interactions; Male; p-Chloroamphetamine; Pindolol; Piperazines; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists | 1994 |
The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Absence; Genetic Predisposition to Disease; Injections, Intraperitoneal; Injections, Intraventricular; Piperazines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
The effect of globopentaosylceramide on a depression model, mouse forced swimming.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Globosides; Male; Mice; Piperazines; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2000 |